employee
employee
Moscow, Russian Federation
employee
CSCSTI 76.29
Traditional methods of psychiatric diagnosis cannot explain the complex interaction between biological and psychopathological factors involved in the development of psychosomatic pathology. This leads to an insufficient understanding of the pathogenetic pathways of its formation and, consequently, to incomplete therapeutic effectiveness. This review analyzes the fundamental biological basis of the development of psychosomatic disorders involving the hypothalamic-pituitary-adrenal axis, neuroinflammation, and mitochondrial dysfunction, which contributes to a better understanding of key pathogenic factors and the optimization of treatment strategies.
psychosomatic disorders, pathogenesis, comorbidity, hypothalamic-pituitary-adrenal system, neuroinflammation
1. Lekcii po psihosomatike / Pod redakciey akademika RAN A.B. Smulevicha. — M.: OOO «Izdatel'stvo «Medicinskoe informacionnoe agentstvo», 2014. — 352 s.: il. Lections on psychosomatics / Ed. by A.B. Smulevich, member of the Russian Academy of Sciences. — M.: Medical Informational Agency, 2014. — 352 p.: ill.
2. Hanna MR, Caspi A, Houts RM, Moffitt TE, Torvik FA. Co-occurrence between mental disorders and physical diseases: a study of nationwide primary-care medical records. Psychol Med. 2024 Nov 18;54(15):1-13. doi:https://doi.org/10.1017/S0033291724002575.
3. Xu W, Jiang W, Ding R, Tao H, Wang Y, Tang Y, Liang D, Wang Y, Wang M, Chen B, Kong Y, Liu L, Yue Y, Tan L, Yu L, Cosci F, Yuan Y; DCPRs Working Group. Study of Rates and Factors Associated to Psychosomatic Syndromes Assessed Using the Diagnostic Criteria for Psychosomatic Research across Different Clinical Settings. Psychother Psychosom. 2024;93(6):386-396. doi:https://doi.org/10.1159/000541404.
4. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006 Jan;27(1):24-31. doi:https://doi.org/10.1016/j.it.2005.11.006.
5. Samushiya, M. A. Psihicheskie rasstroystva u pacientok so zlokachestvennymi opuholyami organov zhenskoy reproduktivnoy sistemy: obzor literatury / M. A. Samushiya // Opuholi zhenskoy reproduktivnoy sistemy. – 2011. – № 1. – S. 86-96. – EDN NUUYTX.
6. Smith, G. D. (2011). Epidemiology, epigenetics and the ‘gloomy prospect’: Embracing randomness in population health research and practice. International Journal of Epidemiology, 40(3), 537–562. doi:https://doi.org/10.1093/ije/dyr117.
7. Halstead, S., Cao, C., Mohr, G. H., Ebdrup, B. H., Pillinger, T., McCutcheon, R. A., … Warren, N. (2024). Prevalence of multimorbidity in people with and without severe mental illness: A systematic review and meta-analysis. The Lancet Psychiatry, 11(6), 431–422.
8. L Niharika, Meenakshi Sharma, V Sarath Babu, Vinod Wasudeorao Chahare 4 The Mind-Body Connection in Stress and Immunity: A Systematic Review. European Journal of cardiovascular Medicine, Open acsess, Volume 14 Issue 6 (Nov - Dec, 2024) | Pages 303 - 306 DOI :https://doi.org/10.5083/ejcm.
9. George MY, Abdel Mageed SS, Mansour DE, Fawzi SF. The cortisol axis and psychiatric disorders: an updated review. Pharmacol Rep. 2025 Dec;77(6):1573-1599. doi:https://doi.org/10.1007/s43440-025-00782-x.
10. Khantakova JN, Mutovina A, Ayriyants KA, Bondar NP. Th17 Cells, Glucocorticoid Resistance, and Depression. Cells. 2023 Nov 30;12(23):2749. doi:https://doi.org/10.3390/cells12232749.
11. Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther. 2011 May;130(2):226-38. doi:https://doi.org/10.1016/j.pharmthera.2011.01.014.
12. Du X, Pang TY. Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases? Front Psychiatry. 2015 Mar 9;6:32. doi:https://doi.org/10.3389/fpsyt.2015.00032.
13. Memiah P, Biadgilign S, Kuhlman J, Cook C, Mburia P, Kingori C, Sarpong D, Buluku G, Hawkins M. Allostatic Load, Single, and Dual Chronic Conditions: Evidence from the National Health and Nutrition Examination Survey. Metab Syndr Relat Disord. 2022 Mar;20(2):104-113. doi:https://doi.org/10.1089/met.2021.0008.
14. Clow A., Thorn L., Evans P., Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress. 2004 Mar;7(1):29-37. doi:https://doi.org/10.1080/10253890410001667205.
15. Hall D.L., Lattie E.G., Antoni M.H., Fletcher M.A., Czaja S., Perdomo D., Klimas N.G. Stress management skills, cortisol awakening response, and post-exertional malaise in Chronic Fatigue Syndrome. Psychoneuroendocrinology. 2014 Nov;49:26-31. doi:https://doi.org/10.1016/j.psyneuen.2014.06.021.
16. Wang, Y.F., You, Gy., Han, T. et al. Network analysis of comorbid depression, suicidality and biomarkers on HPA axis among mood disorder patients to psychiatric emergency services. Transl Psychiatry 13, 203 (2023). https://doi.org/10.1038/s41398-023-02503-5.
17. Wilkowska A., Rynkiewicz A., Wdowczyk J., Landowski J. Morning and afternoon serum cortisol level in patients with post-myocardial infarction depression. Cardiol J. 2019;26(5):550-554. doi:https://doi.org/10.5603/CJ.a2017.0123.
18. Hage M.P., Azar S.T. The Link between Thyroid Function and Depression. J Thyroid Res. 2012;2012:590648. doi:https://doi.org/10.1155/2012/590648.
19. Perroud, N., Paoloni-Giacobino, A., Prada, P. et al. Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma. Transl Psychiatry 1, e59 (2011). https://doi.org/10.1038/tp.2011.60.
20. Shields A.E., Wise L.A., Ruiz-Narvaez E.A., Seddighzadeh B., Byun H.M., Cozier Y.C., Rosenberg L., Palmer J.R., Baccarelli A.A. Childhood abuse, promoter methylation of leukocyte NR3C1 and the potential modifying effect of emotional support. Epigenomics. 2016 Nov;8(11):1507-1517. doi:https://doi.org/10.2217/epi-2016-0074.
21. Ding Y., Wei Z., Yan H., Guo W. Efficacy of Treatments Targeting Hypothalamic-Pituitary-Adrenal Systems for Major Depressive Disorder: A Meta-Analysis. Front Pharmacol. 2021 Sep 10;12:732157. doi:https://doi.org/10.3389/fphar.2021.732157.
22. Magaeva S.V., Morozov S.G., Gribova I.E. .Psihoneyroimmunologiya kak oblast' psihosomatiki Magaeva S.V., Morozov S.G., Gribova I.E. Neyroimmunologiya Tom IV, № 3-4, 2006, s.4 -15 Psychoneuroimmunology as psychosomatics Magaeva S.V., Morozov S.G., Gribova I.E. Antioxidants in Prevention and Treatment. Antioxidants (Basel). 2021 Sep 9;10(9):1439. doi:https://doi.org/10.3390/antiox10091439.
23. Daniel F. (2024). Understanding the Mechanisms of Psychoneuroimmunology in Chronic Illness. J Psychol Psychother. 14:497. DOI:https://doi.org/10.35841/2161-0487.24.14.497
24. Miller, A., Raison, C. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16, 22–34 (2016). https://doi.org/10.1038/nri.2015.5.
25. Osimo E.F., Pillinger T., Rodriguez I.M., Khandaker G.M., Pariante C.M., Howes OD. Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain, behavior, and immunity. 2020;87:901–909.
26. Pitharouli M.C., Hagenaars S.P., Glanville K.P., Coleman J.R.I., Hotopf M., Lewis C.M., Pariante C.M. Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank. The American journal of psychiatry. 2021;178:522–529.. https://doi.org/10.1176/appi.ajp.2020.20060947.
27. Laurans L, Venteclef N, Haddad Y, et al Genetic deficiency of indoleamine 2, 3-dioxygenase promotes gut microbiota-mediated metabolic health. Nat Med. 2018;24(8):1113–1120. doi:https://doi.org/10.1038/s41591-018-0060-4.
28. Beckett, C.W., Niklison-Chirou, M.V. The role of immunomodulators in treatment-resistant depression: case studies. Cell Death Discov. 8, 367 (2022). https://doi.org/10.1038/s41420-022-01147-6.
29. Goshi N., Lam D., Bogguri C., George V.K., Sebastian A., Cadena J., Leon N.F., Hum N.R., Weilhammer D.R., Fischer N.O. and Enright H.A. (2025) Direct effects of prolonged TNF-α and IL-6 exposure on neural activity in human iPSC-derived neuron-astrocyte co-cultures. Front. Cell. Neurosci. 19:1512591. doi:https://doi.org/10.3389/fncel.2025.1512591.
30. Kelley N., Jeltema D., Duan Y., He Y. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int J Mol Sci. 2019 Jul 6;20(13):3328. doi:https://doi.org/10.3390/ijms20133328.
31. Zhang Y., Liu L., Liu Y.Z., Shen X.L., Wu T.Y., Zhang T., Wang W., Wang Y.X., Jiang C.L. NLRP3 Inflammasome Mediates Chronic Mild Stress-Induced Depression in Mice via Neuroinflammation. Int J Neuropsychopharmacol. 2015 Jan 20;18(8):pyv006. doi:https://doi.org/10.1093/ijnp/pyv006.
32. Yang X-J, Zhao B-C, Li J, Shi C, Song Y-Q, Gao X-Z, Jiang H-L, Yu Q-Y, Liang X-C, Feng S-X, Li X, Sun Y, Li Y-H, Wang Y-P, Bao T and Zhang Z-J (2022) Serum NLRP3 Inflammasome and BDNF: Potential Biomarkers Differentiating Reactive and Endogenous Depression. Front. Psychiatry 13:814828. doi:https://doi.org/10.3389/fpsyt.2022.814828.
33. Uzbekov M.G., Shihov S.N., Kryukov V.V., Krasnov V.N., Strelkova I.M., Uzbekova D.G. Issledovanie dinamiki soderzhaniya ciliarnogo neyrotroficheskogo faktora v syvorotke krovi bol'nyh melanholicheskoy depressiey na fone farmakoterapii venlafaksinom. Sibirskiy vestnik psihiatrii i narkologii. 2020; 3 (108): 5–10. https://doi.org/10.26617/1810-3111-2020-3(108)-5-10.
34. Takata F., Nakagawa S., Matsumoto J., Dohgu S. Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction. Front. Cell. Neurosci. 2021;15:661838. doi:https://doi.org/10.3389/fncel.2021.661838.
35. Millett C.E., Burdick K.E., Kubicki M.R. The Effects of Peripheral Inflammation on the Brain-A Neuroimaging Perspective. Harv Rev Psychiatry. 2022 Jan-Feb 01;30(1):54-58. doi:https://doi.org/10.1097/HRP.0000000000000323.
36. Köhler O., Benros M.E., Nordentoft M., et al. Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Psychiatry. 2014;71(12):1381–1391. doihttps://doi.org/10.1001/jamapsychiatry.2014.1611.
37. Du Y., Dou Y., Wang M., Wang Y., Yan Y., Fan H., Fan N., Yang X. and Ma X (2024) Efficacy and acceptability of anti-inflammatory agents in major depressive disorder: a systematic review and meta-analysis. Front. Psychiatry 15:1407529. doi:https://doi.org/10.3389/fpsyt.2024.1407529.
38. Siuchnińska H., Minarowska A., Wasilewska E. Beyond Joints: Neuropsychiatric Benefits of TNF-α and IL-6 Inhibitors in Rheumatoid Arthritis-Narrative Review. Int J Mol Sci. 2025 Aug 28;26(17):8361. doi:https://doi.org/10.3390/ijms26178361.
39. Kim K.H., Lee C.B. Socialized mitochondria: mitonuclear crosstalk in stress. Exp Mol Med. 2024 May;56(5):1033-1042. doi:https://doi.org/10.1038/s12276-024-01211-4.
40. Brivio, P., Audano, M., Gallo, M.T. et al. Metabolomic signature and mitochondrial dynamics outline the difference between vulnerability and resilience to chronic stress. Transl Psychiatry 12, 87 (2022). https://doi.org/10.1038/s41398-022-01856-7.
41. Picard M., McEwen B.S. Psychological Stress and Mitochondria: A Systematic Review. Psychosom Med. 2018 Feb/Mar;80(2):141-153. doi:https://doi.org/10.1097/PSY.0000000000000545.
42. Giménez-Palomo A., Dodd S., Anmella G., Carvalho A.F., Scaini G., Quevedo J., Pacchiarotti I., Vieta E. and Berk M. (2021) The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment. Front. Psychiatry 12:546801. doi:https://doi.org/10.3389/fpsyt.2021.546801.
43. Fu Q., Li J., Zhu H., Yu Q., Shen T., Liu Z., Liu Y., Zhou W. Mitochondrial dysfunction, a new marker warning of neuropsychiatric disorder risk: evidence from genetics and epidemiology. Ann Gen Psychiatry. 2025 Oct 22;24(1):64. doi:https://doi.org/10.1186/s12991-025-00604-7.
44. Picard M., Trumpff C., Burelle Y. Mitochondrial Psychobiology: Foundations and Applications. Curr Opin Behav Sci. 2019 Aug;28:142-151. doi:https://doi.org/10.1016/j.cobeha.2019.04.015.
45. Kealy J., Greene C., Campbell M. Blood-brain barrier regulation in psychiatric disorders. Neurosci Lett. 2020 May 1;726:133664. doi:https://doi.org/10.1016/j.neulet.2018.06.033.
46. Jorgensen A., Baago I.B., Rygner Z., et al. Association of Oxidative Stress–Induced Nucleic Acid Damage With Psychiatric Disorders in Adults: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2022;79(9):920–931. doihttps://doi.org/10.1001/jamapsychiatry.2022.2066.
47. Zengil S. and Laloğlu E. (2024) The effect of major depressive disorder comorbidity on ischemia-modified albumin levels, a marker of oxidative stress, and antioxidant defense system in patients with obsessive compulsive disorder. Front. Psychiatry 15:1469640. doi:https://doi.org/10.3389/fpsyt.2024.1469640.
48. Magalhães PLM, da Silva AMP, Maximiano MLB, Fernandes JVA, Amaral DC, Fortes AAT, Filho HNF, Silva LO, Teixeira BDDS, Franco ES, Maia MBS. Effects of Coenzyme Q10 Supplementation on Depressive Symptoms and Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Psychopharmacol. 2026 Jan-Feb 01;46(1):93-100. doi:https://doi.org/10.1097/JCP.0000000000002112.
49. Russell S.E., Skvarc D.R., Mohebbi M., Camfield D., Byrne L.K., Turner A., Ashton M.M., Berk M., Dodd S., Malhi G.S., Cotton S.M., Bush A.I., Dean O.M. The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial. Clin Psychopharmacol Neurosci. 2023 May 30;21(2):320-331. doi:https://doi.org/10.9758/cpn.2023.21.2.320.
50. Kondo D.G., Forrest L.N., Shi X., Sung Y.H., Hellem T.L., Huber R.S., Renshaw P.F. Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression. Amino Acids. 2016 Aug;48(8):1941-54. doi:https://doi.org/10.1007/s00726-016-2194-3.
51. Nussbaumer M., Asara J.M., Teplytska L., Murphy M.P., Logan A., Turck C.W., Filiou M.D. Selective Mitochondrial Targeting Exerts Anxiolytic Effects In Vivo. Neuropsychopharmacology. 2016 Jun;41(7):1751-8. doi:https://doi.org/10.1038/npp.2015.341.
52. Khandaker, G.M., Zuber, V., Rees, J.M.B. et al. Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort. Mol Psychiatry 25, 1477–1486 (2020). https://doi.org/10.1038/s41380-019-0395-3.
